CARL Share Price Performance
US$13.12
-1.38 (-9.52%)
Price US$13.12
Share PriceUS$13.12
Carlsmed, Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 2 Fair Values set on narratives written by author
CARL Community Narratives
There are no narratives available yet.
Carlsmed, Inc. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.99
- Gross Margin
- 74.02%
- Net Profit Margin
- -68.47%
- Debt/Equity Ratio
- 60.1%
Carlsmed, Inc. Competitors
Snowflake Analysis
About CARL
- Founded
- 2018
- Employees
- 100
- CEO
- WebsiteView website
Carlsmed, Inc., a commercial-stage company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
Market Insight
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading
U.S. Market Performance
- 7 Days: -2.8%
- 3 Months: 5.3%
- 1 Year: 13.4%
- Year to Date: 11.7%
Over the last 7 days, the market has dropped 2.8%, driven by a decline of 2.5% in the Information Technology sector. In contrast to the last week, the market is actually up 13% over the past year. Looking forward, earnings are forecast to grow by 15% annually. Market details ›